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Evidence-based Management 
of Hypertension is divided into 
15 chapters, each authored or 
co authored by a leading expert. 
The book is edited by Matthew R. 
Weir, professor of medicine, who 
himself is a leading hypertension 
specialist. The objective of the book 
is to answer several questions: 
(1) whom to treat, when to start, 
and how low to go;
(2) what therapies to use;
(3) whether pre-hypertension 
should be treated;
(4) whether the choice of 
therapy should change in the 
presence of comorbidities 
such as ischemic heart disease, 
obesity, diabetes, chronic 
kidney disease, and so on.
At the outset, the editor lays 
the foundation of the book 
by outlining the levels of evi-
dence, from 1a to 4, and grades 
of evidence, from A to D. These 
criteria have been widely used 
to rate the quality of evidence in 
other evidence-based guidelines. 
Using these criteria, authors were 
asked to rate and grade the level 
of evidence in a table at the end 
of their chapter. In addition, they 
were asked to summarize the key 
recommendations.
I reviewed the book by start-
ing at the end of each chapter, 
reading the summary and evi-
dence rating. This provoked me 
to read the evidence base that led 
to the conclusions. The rating of 
the evidence and conclusions 
remains the subjective opinion 
of the authors. There is nothing 
wrong with this subjectivity; it 
points out that evidence-based 
medicine is also an art. As an 
example, two sets of authors who 
reviewed the evidence on goal 
blood pressure in patients with 
chronic kidney disease reached 
markedly different conclusions. 
In chapter 1, Basile and Moser 
conclude that among patients 
with chronic kidney disease, 
reduction of blood pressure to 
less than 140/90 mm Hg is opti-
mal to reduce cardiovascular 
and renal outcomes. The level of 
evidence was rated 1b (at least 
one randomized trial to sup-
port) and graded A (high-quality 
study). In contrast, in chapter 
14, Kalaitzidis and Bakris con-
clude that among patients with 
diabetic nephropathy, blood 
pressure should be reduced to 
less than 130/80 mm Hg. They 
rated the evidence 1a (supported 
by systematic review and meta-
analysis) and graded it A. Given 
that data to support firm rec-
ommendations in this area are 
sparse, the reader can appreciate 
why the authors reached differ-
ent conclusions after examining 
the supporting data.
As is true of many books 
printed on paper, some of the 
information is dated. As exam-
ples, two meta-analyses on the 
use of antihypertensive drugs 
among dialysis patients are 
not mentioned. Meta-analyses, 
according to the rating table of 
this book, would qualify for the 
highest level of evidence (1a). 
Although the first chapter men-
tions the findings of the Action 
to Control Cardiovascular Risk 
in Diabetes (ACCORD) trial, 
the chapter dealing with diabe-
tes and hypertension does not. 
Nonetheless, these are minor 
shortcomings. The overall effort 
by the authors is tremendous and 
laudable.
To those with not much time 
on their hands, I would sug-
gest reading the summary of the 
evidence base of each chapter. 
To those interested in hyperten-
sion, I would suggest reading 
the data that form the evidence 
base. Thus, this well-written 
book can serve the needs of 
many types of readers, from the 
medical student to the specialist. 
I would recommend it to anyone 
interested in exploring the evi-
dence base of hypertension.
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